Pharmacy Operationalization of the Intralesional Oncolytic Immunotherapy Talimogene Laherparepvec
Sign Up to like & getrecommendations! Published in 2018 at "Hospital Pharmacy"
DOI: 10.1177/0018578717749926
Abstract: Objective: Oncolytic immunotherapy involves the use of viruses to target and destroy cancer cells and to induce immune responses for an enhanced antitumor effect. Talimogene laherparepvec, a genetically modified herpes simplex virus type 1 (HSV-1)… read more here.
Keywords: talimogene; talimogene laherparepvec; pharmacy operationalization; oncolytic immunotherapy ... See more keywords